Frank Schirripa, DO in Staten Island, NY - Medicare Pain Medicine

Frank Schirripa, DO is a medicare enrolled "Pain Medicine - Pain Medicine" physician in Staten Island, New York. His current practice location is 475 Seaview Avenue, Staten Island, New York. You can reach out to his office (for appointments etc.) via phone at (646) 938-6598.

Frank Schirripa is licensed to practice in New York (license number 307806-01) and he also participates in the medicare program. He does not accept medicare assignments directly but he may accept medicare through third-party (refer to Reassignment section below) and may also prescribe medicare part D drugs. His NPI Number is 1902330491.

Contact Information

	Frank Schirripa, DO
	475 Seaview Avenue, Staten Island, NY 10305
	(646) 938-6598
	Not Available

Physician's Profile

Full Name	Frank Schirripa
Gender	Male
Speciality	Pain Medicine - Pain Medicine
Location	475 Seaview Avenue, Staten Island, New York
Accepts Medicare Assignments	Medicare enrolled and may accept medicare through third-party reassignment. May prescribe medicare part D drugs.

NPI Data:

NPI Number: 1902330491
Provider Enumeration Date: 04/12/2017
Last Update Date: 08/10/2021

Medicare PECOS Information:

PECOS PAC ID: 9436495165
Enrollment ID: I20221005000928

Medical Identifiers

Medical identifiers for Frank Schirripa such as npi, medicare ID, medicare PIN, medicaid, etc.

Identifier	Type	State	Issuer
1902330491	NPI	-	NPPES

Medical Taxonomies and Licenses

Taxonomy	Type	License (State)	Status
208VP0000X	Pain Medicine - Pain Medicine	307806-01 (New York)	Primary

Medicare Reassignments

Some practitioners may not bill the customers directly but medicare billing happens through clinics / group practice / hospitals where the provider works. Medicare reassignment of benefits is a mechanism by which practitioners allow third parties to bill and receive payment for medicare services performed by them. Frank Schirripa allows following entities to bill medicare on his behalf.

Entity Name	True North Medical Group Pc
Entity Type	Part B Supplier - Clinic/group Practice
Entity Identifiers	NPI Number: 1659883486 PECOS PAC ID: 7012194806 Enrollment ID: O20171229000536

News Archive

Blue Shield Life and Health imposes excessive rate increase on over 80,000 Californians

Blue Shield Life and Health is imposing an unreasonable rate increase on over 80,000 Californians with individual health insurance policies, an average of 9.8% that adds up to a 22.8% increase for the year. California Insurance Commissioner Dave Jones announced today that the company would not budge on its excessive rate hike.

Taiwan approves WTO amendment allowing countries to export lower-cost versions of antiretrovirals, other drugs to developing countries

Taiwan's legislative body the Yuan on Thursday approved the first reading of a proposed World Trade Organization amendment that would allow pharmaceutical companies to make lower-cost versions of generic antiretroviral drugs, as well as drugs for malaria and other diseases, to sell to developing countries, the CNA/Taipei Times reports.

Environmental surface testing at radiation oncology clinic showed no detectable SARS-CoV2

A Rutgers Cancer Institute of New Jersey study shows environmental surface testing at the center's Radiation Oncology Department located within Robert Wood Johnson University Hospital, an RWJBarnabas Health facility, during the height of the COVID-19 pandemic in the state showed no detectable SARS-CoV2 – the virus that causes COVID-19

Apexigen enters collaboration with Centocor R&D for antibody discovery

Apexigen, Inc. announced today that it has entered into a collaboration and worldwide license agreement with Centocor Research & Development, Inc. and its affiliates to utilize Apexigen's proprietary therapeutic antibody technologies to discover and develop monoclonal antibody drugs. Apexigen will generate and screen antibodies to several targets specified by Centocor R&D, which will be responsible for development and commercialization of all products resulting from the collaboration.

Medicare Part D Prescriber Enrollment

Any physician or other eligible professional who prescribes Part D drugs must either enroll in the Medicare program or opt out in order to prescribe drugs to their patients with Part D prescription drug benefit plans. Frank Schirripa is enrolled with medicare and thus, if eligible, can prescribe medicare part D drugs to patients with medicare part D benefits.

Mailing Address and Practice Location

Mailing Address	Practice Location Address
Frank Schirripa, DO 475 Seaview Ave, Staten Island, NY 10305-3436 Ph: (646) 938-6598	Frank Schirripa, DO 475 Seaview Avenue, Staten Island, NY 10305 Ph: (646) 938-6598

News Archive

Blue Shield Life and Health imposes excessive rate increase on over 80,000 Californians

Taiwan approves WTO amendment allowing countries to export lower-cost versions of antiretrovirals, other drugs to developing countries

Environmental surface testing at radiation oncology clinic showed no detectable SARS-CoV2

Apexigen enters collaboration with Centocor R&D for antibody discovery

Pain Medicine Doctors in Staten Island, NY

Bahram Jahanbakhsh, M.D. Pain Medicine Medicare: Accepting Medicare Assignments Practice Location: 475 Seaview Ave, Staten Island, NY 10305 Phone: 718-226-9292
Mr. Keyvan Jahanbakhsh, MD Pain Medicine Medicare: Accepting Medicare Assignments Practice Location: 1534 Victory Blvd, Staten Island, NY 10314 Phone: 718-667-3577 Fax: 347-875-1804
Dr. Anne Marie Stilwell, M.D. Pain Medicine Medicare: Accepting Medicare Assignments Practice Location: 45 Mcclean Ave, Staten Island, NY 10305 Phone: 718-448-6373 Fax: 718-448-6648
Uel Joseph Alexis, M.D. Pain Medicine Medicare: Accepting Medicare Assignments Practice Location: 1360 Hylan Blvd, Staten Island, NY 10305 Phone: 718-667-3577 Fax: 718-351-7151

Frank Schirripa, DO - Medicare Pain Medicine in Staten Island, NY

Contact Information

Physician's Profile

Medical Identifiers

Medical Taxonomies and Licenses

Medicare Reassignments

Blue Shield Life and Health imposes excessive rate increase on over 80,000 Californians

Taiwan approves WTO amendment allowing countries to export lower-cost versions of antiretrovirals, other drugs to developing countries

Environmental surface testing at radiation oncology clinic showed no detectable SARS-CoV2

Apexigen enters collaboration with Centocor R&D for antibody discovery

Medicare Part D Prescriber Enrollment

Mailing Address and Practice Location

Blue Shield Life and Health imposes excessive rate increase on over 80,000 Californians

Taiwan approves WTO amendment allowing countries to export lower-cost versions of antiretrovirals, other drugs to developing countries

Environmental surface testing at radiation oncology clinic showed no detectable SARS-CoV2

Apexigen enters collaboration with Centocor R&D for antibody discovery

Pain Medicine Doctors in Staten Island, NY